Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Argos Therapeutics logo — company profile

Argos Therapeutics

Founded 1997 Post Ipo Equity Total: $238.93M Biotechnology, Health Care +1

General Information

Company Name Argos Therapeutics
Founded Year 1997
Founders / Decision Makers
Team member Team member Team member Team member Team member
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Argos Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Argos Therapeutics

Argos Therapeutics is a biotechnology company established in 1997 and based in Durham, North Carolina. The company focuses on the development of immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. Argos Therapeutics conducts clinical trial programs for cancer and human immunodeficiency virus. Its product lineup includes AGS-0031 for metastatic renal cell carcinoma, AGS-0041 for HIV, CD83 soluble protein for transplant rejection/autoimmune disorders, Anti IFN-alpha monoclonal antibody2 for lupus, and regulatory T cell therapy3 for autoimmune disorders. Previously known as MERIX Bioscience, Inc., Argos Therapeutics secured a $1.50M investment in Post-IPO Equity at 10 January 2018. The investment was made by undisclosed investors. With its focus on addressing critical medical needs through innovative immunotherapy solutions, Argos Therapeutics is positioned to make a significant impact in the biotechnology and health care industries.

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 10 Jan 2018
Post-IPO Equity •••••• 2
Investor
•••• •••• 		15 Mar 2016
Post-IPO Equity •••••• - 15 Apr 2015
Post-IPO Debt •••••• 1
Investor
30 Sep 2014
Series E •••••• 10
Investor Investor Investor Investor Investor Investor
•••• •••• 		20 Nov 2013

View All 15 Funding Rounds

Argos Therapeutics Alternatives & Competitors

Argos Therapeutics vs
Xanthus Pharmaceuticals
Xanthus Pharmaceuticals

Innovative treatments for cancer and autoimmune disorders through pioneering small-molecule therapeu...

Series B
Biopharma, Biotechnology
Argos Therapeutics vs
TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. United States

TRACT Therapeutics, Inc. has developed a novel approach for restoring immune balance in patients rec...

Series Unknown
6 employees
Health Care
Argos Therapeutics vs
iCell Gene Therapeutics
iCell Gene Therapeutics United States

iCell Gene Therapeutics is a clinical-stage biopharmaceutical company developing chimeric antigen re...

8 employees
Biotechnology

FAQ About Argos Therapeutics

Argos Therapeutics, Inc., a biotechnology company, develops immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company conducts clinical trial programs in cancer and human immunodeficiency virus. Its product lineup includes AGS-0031 for metast...
Argos Therapeutics was founded in 1997.
Argos Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Argos Therapeutics has completed 15 funding rounds, raising a total of $238.93M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Argos Therapeutics include Xanthus Pharmaceuticals, TRACT Therapeutics, Inc., iCell Gene Therapeutics, NextGen Immuno Therapeutics, Kojin Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Argos Therapeutics and Xanthus Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Argos Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy